Suchergebnisse - "Collier, Dami"

PubPharm (38)

21

Dramatic impact of rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study

enthalten in: bioRxiv.org | 2021

von Collier, D. | Assennato, S. | Warne, B. | +29

22

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

enthalten in: Cell reports. Medicine | 2020

von Mlcochova, P. | Collier, D. | Ritchie, A. | +134

23

Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients : A Clinical Validation Trial and Implementation Study

enthalten in: Cell reports. Medicine | 2020

von Collier, D. | Assennato, S. | Warne, B. | +82

24

Active and passive case-finding in tuberculosis-affected households in Peru : a 10-year prospective cohort study

enthalten in: The Lancet. Infectious diseases | 2019

von Saunders, M. | Tovar, M. | Collier, D. | +5

CommentIn: Lancet Infect Dis. 2019 May;19(5):456-457. - PMID 30910430

25

HIV Cerebrospinal Fluid Escape and Neurocognitive Pathology in the Era of Combined Antiretroviral Therapy : What Lies Beneath the Tip of the Iceberg in Sub-Saharan Africa?

enthalten in: Brain sciences | 2018

von Collier, D. | Haddow, L. | Brijkumar, J. | +3

26

Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Kugathasan, R. | Collier, D. | Haddow, L. | +5

27

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting : A Competing-Risks Prospective Cohort Analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2017

von Collier, D. | Iwuji, C. | Derache, A. | +7

28

Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

Erschienen: 2017

von Collier, D. | Iwuji, C. | Derache, A. | +6

29

Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms

Erschienen: 2017

von Kugathasan, R. | Collier, D. | Haddow, L. | +5

30

Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency

enthalten in: Scientific reports | 2016

von Sutherland, K. | Collier, D. | Claiborne, D. | +5